Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live

Coalition for Epidemic Preparedness Innovations & Gilead Sciences

3 shared events · Importance 3 · Last updated Jun 11, 2026

Importance
3
Shared Events
3
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
42
International
Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) is funding three groups, including Moderna and the University of Oxford, to accelerate the development of vaccines against the Bundibugyo strain of Ebola.
Gilead Sciences: Gilead Sciences' experimental oral COVID antiviral drug, Obeldesivir, is being considered for use as a preventative treatment for Ebola contacts, under strict protocol.
May 21, 2026 · 627 articles
39
Accidents
Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) funds vaccine development and is assessing potential Ebola vaccine candidates, aiming for a rapid response.
Gilead Sciences: Gilead Sciences' antiviral drug remdesivir and experimental drug obeldesivir are being prioritized for clinical trials to treat or prevent the Bundibugyo ebolavirus, indicating its significant role in potential therapies.
May 18, 2026 · 505 articles
24
Accidents
Coalition for Epidemic Preparedness Innovations: CEPI is listed as a partner in the urgent coordination meeting convened by Africa CDC, indicating potential involvement in the response to the Ebola outbreak.
Gilead Sciences: Gilead Sciences is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
NEWSDESK
Explore this relationship live

Track how Coalition for Epidemic Preparedness Innovations and Gilead Sciences interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.